Prevention of rhabdomyolysis‐induced acute kidney injury – A DASAIM/DSIT clinical practice guideline

• Published in: Acta anaesthesiologica Scandinavica 2019-05, Vol.63 (5), p.576-586
• Main Authors: Michelsen, Jens, Cordtz, Joakim, Liboriussen, Lisbeth, Behzadi, Meike T., Ibsen, Michael, Damholt, Mette B., Møller, Morten H., Wiis, Jørgen
• Format: Article
• Language: English
• Subjects: Acute Kidney Injury - prevention & control; Antioxidants; Antioxidants - therapeutic use; Clinical practice guidelines; Colloids; Diuretics; Diuretics - therapeutic use; Evaluation; Fluid Therapy; Humans; Injury prevention; Kidneys; Mannitol; Practice Guidelines as Topic; Psychic phenomena; Quality; Renal Replacement Therapy; Resuscitation; Rhabdomyolysis; Rhabdomyolysis - complications; Sodium; Sodium bicarbonate; Therapy; Trustworthiness
• ISSN: 0001-5172; 1399-6576
• DOI: 10.1111/aas.13308

Background Rhabdomyolysis‐induced acute kidney injury (AKI) is a common and serious condition. We aimed to summarise the available evidence on this topic and provide recommendations according to current standards for trustworthy guidelines. Methods This guideline was developed using Grading of Recommendations Assessment, Development, and Evaluation (GRADE). The following preventive interventions were assessed: (a) fluids, (b) diuretics, (c) alkalinisation, (d) antioxidants, and (e) renal replacement therapy. Exclusively patient‐important outcomes were assessed. Results We suggest using early rather than late fluid resuscitation (weak recommendation, very low quality of evidence). We suggest using crystalloids rather than colloids (weak recommendation, low quality of evidence). We suggest against routine use of loop diuretics as compared to none (weak recommendation, very low quality of evidence). We suggest against use of mannitol as compared to none (weak recommendation, very low quality of evidence). We suggest against routine use of any diuretic as compared to none (weak recommendation, very low quality of evidence). We suggest against routine use of alkalinisation with sodium bicarbonate as compared to none (weak recommendation, low quality of evidence). We suggest against the routine use of any alkalinisation as compared to none (weak recommendation, low quality of evidence). We suggest against routine use of renal replacement therapy as compared to none (weak recommendation, low quality of evidence). For the remaining PICO questions, no recommendations were issued. Conclusion The quantity and quality of evidence supporting preventive interventions for rhabdomyolysis‐induced AKI is low/very low. We were able to issue eight weak recommendations and no strong recommendations.